<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Molecular Biology - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcmolbiol/</link>
		<description>The latest articles from BMC Molecular Biology (ISSN 1471-2199) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/83"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/82"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/81"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/80"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/79"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/78"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/77"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/76"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/75"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2199/9/74"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/83">
            
            <title>Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells </title>
			<description>Background:
CCAAT/Enhancer Binding Proteindelta (C/EBPdelta) is a member of the highly conserved C/EBP family of leucine zipper (bZIP) proteins.   C/EBPdelta is highly expressed in G0 growth arrested mammary epithelial cells (MECs) and "loss of function" alterations in C/EBPdelta have been associated with impaired contact inhibition, increased genomic instability and increased cell migration.  Reduced C/EBPdelta expression has also been reported in breast cancer and acute myeloid leukemia (AML).  C/EBPdelta functions as a transcriptional activator, however, only a limited number of C/EBPdelta target genes have been reported.  As a result, the role of C/EBPdelta in growth control and the potential mechanisms by which "loss of function" alterations in C/EBPdelta contribute to tumorigenesis are poorly understood.   The goals of the present study were to identify C/EBPdelta target genes using Chromatin Immunoprecipitation coupled with a CpG Island (HCG12K) Array gene chip ("ChIP-chip") assay and to assess the expression and potential functional roles of C/EBPdelta target genes in growth control.   
Results:
ChIP-chip assays identified ~100 C/EBPdelta target gene loci which were classified by gene ontology (GO) into cell adhesion, cell cycle regulation, apoptosis, signal transduction, intermediary metabolism, gene transcription, DNA repair and solute transport categories.  Conventional ChIP assays validated the ChIP-chip results and demonstrated that 14/14 C/EBPdelta target loci were bound by C/EBPdelta in G0 growth arrested MCF-12A MECs.  Gene-specific RT-PCR analysis also demonstrated C/EBPdelta-inducible expression of 14/14 C/EBPdelta target genes in G0 growth arrested MCF-12A MECs.   Finally, expression of endogenous C/EBPdelta and selected C/EBPdelta target genes was also demonstrated in contact-inhibited G0 growth arrested nontransformed human MCF-10A MECs and in mouse HC11 MECs. The results demonstrate consistent activation and downstream function of C/EBPdelta in growth arrested human and murine MECs. 
Conclusions:
C/EBPdelta target genes were identified by a global gene array approach and classified into functional categories that are consistent with biological contexts in which C/EBPdelta is induced, such as contact-mediated G0 growth arrest, apoptosis, metabolism and inflammation.  The identification and validation of C/EBPdelta target genes provides new insights into the mechanistic role of C/EBPdelta in mammary epithelial cell biology and sheds new light on the potential impact of "loss of function" alterations in C/EBPdelta in tumorigenesis. </description>
			<link>http://www.biomedcentral.com/1471-2199/9/83</link>
			
			 	<dc:creator>Yingjie Zhang, Tong Liu, Pearlly Yan, Tim Huang and Jim DeWille</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:83</dc:source>
			<dc:date>2008-10-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-83</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>83</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/82">
            
            <title>Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet </title>
			<description>Background:
Pioglitazone was reported to improve hepatic steatosis and necroinflammation in human studies. To investigate whether the hepato-protective effect of pioglitazone was associated with an improvement of antioxidant defense mechanism, oxidative DNA damage and repair activity were determined in a high fat diet model. Male C57BL/6 mice were respectively fed with a 30% fat diet, the same diet with pioglitazone 100 mg/kg/day, or a chow diet as control for 8 weeks. Tissue oxidative stress was indicated by malondialdehyde concentration. Oxidative DNA damage was detected by immunohistochemical 8-oxoG staining. Enzymatic antioxidant defense was detected by the real-time PCR of superoxide dismutase (Sod1, Sod2) and DNA glycosylase (Ogg1, MutY). Oxidative DNA repair was detected by immunohistochemical staining and western blotting of OGG1 expression. 
Results:
Our results show that hepatic steatosis was induced by a high-fat diet and improved by adding pioglitazone. Malondialdehyde concentration and 8-oxoG staining were strongly increased in the high-fat diet group, but attenuated by pioglitazone. Gene expressions of antioxidant defense mechanism: Sod1, Sod2, Ogg1 and MutY significantly decreased in the high-fat diet group but reversed by pioglitazone co-administration. 
Conclusion:
The attenuation of hepatic oxidative DNA damage by pioglitazone in a high-fat diet may be mediated by up-regulation of the antioxidant defense mechanism and oxidative DNA repair activity. The diminution of oxidative damage may explain the clinical benefit of pioglitazone treatment in patients with non-alcoholic fatty liver disease.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/82</link>
			
			 	<dc:creator>Pi-Jung Hsiao, Tusty-Jiuan Hsieh, Kung-Kai Kuo, Wei-Wen Hung, Kun-Bow Tsai, Ching-Hsiu Yang, Ming-Lung Yu and Shyi-Jang Shin</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:82</dc:source>
			<dc:date>2008-09-26</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-82</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>82</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/81">
            
            <title>Regulation of expression of two LY-6 family genes by intron retention and transcription induced chimerism</title>
			<description>Background:
Regulation of the expression of particular genes can rely on mechanisms that are different from classical transcriptional and translational control. The LY6G5B and LY6G6D genes encode LY-6 domain proteins, whose expression seems to be regulated in an original fashion, consisting of an intron retention event which generates, through an early premature stop codon, a non-coding transcript, preventing expression in most cell lines and tissues.
Results:
The MHC LY-6 non-coding transcripts have shown to be stable and very abundant in the cell, and not subject to Nonsense Mediated Decay (NMD). This retention event appears not to be solely dependent on intron features, because in the case of LY6G5B, when the intron is inserted in the artificial context of a luciferase expression plasmid, it is fully spliced but strongly stabilises the resulting luciferase transcript. In addition, by quantitative PCR we found that the retained and spliced forms are differentially expressed in tissues indicating an active regulation of the non-coding transcript. EST database analysis revealed that these genes have an alternative expression pathway with the formation of Transcription Induced Chimeras (TIC). This data was confirmed by RT-PCR, revealing the presence of different transcripts that would encode the chimeric proteins CSNK&#946;-LY6G5B and G6F-LY6G6D, in which the LY-6 domain would join to a kinase domain and an Ig-like domain, respectively.
Conclusion:
In conclusion, the LY6G5B and LY6G6D intron-retained transcripts are not subjected to NMD and are more abundant than the properly spliced forms. In addition, these genes form chimeric transcripts with their neighbouring same orientation 5' genes. Of interest is the fact that the 5' genes (CSNK&#946; or G6F) undergo differential splicing only in the context of the chimera (CSNK&#946;-LY6G5B or G6F-LY6G6C) and not on their own.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/81</link>
			
			 	<dc:creator>Vincenzo Calvanese, Meera Mallya, R Duncan Campbell and Bego&#241;a Aguado</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:81</dc:source>
			<dc:date>2008-09-25</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-81</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>81</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/80">
            
            <title>Sense and Antisense OsDof12 Transcripts in Rice</title>
			<description>Background:
Antisense transcription is a widespread phenomenon in plants and mammals. Our previous data on rice gene expression analysis by microarray indicated that the sense and antisense transcripts at the OsDof12 locus were co-expressed in leaves. In current study, we analyzed the expression patterns in detail and looked for the possible mechanism related to their expression patterns.
Results:
OsDof12, being a single copy gene located on rice chromosome 3, encodes a predicted Dof protein of 440 amino acids with one intron of 945bp. The antisense transcript, OsDofl2os, overlaps with both the exonic and intronic regions of OsDof12 and encodes a functionally unknown protein of 104 amino acids with no intron. The sense-antisense OsDof12 transcripts were co-expressed and not tissue-specific in general. At different developmental stages in rice, the OsDof12 and OsDof12os transcripts exhibited reciprocal expression patterns. Interestingly, the expression of both genes was significantly induced under drought treatment, and inhibited by dark treatment. In transgenic rice plants containing the GUS gene, under the control of the OsDof12 and OsDofl2os promoters, the expression profiles of GUS were consistent with those of OsDof12 and OsDof12os, respectively. In addition, the analysis of cis-regulatory elements within the promoter regions of the two transcripts indicated that either of the two promoters contained 74 classes of cis-regulatory elements, of which the two promoter regions shared 53 classes.
Conclusion:
Based on the expression profiles of OsDof12 and OsDof12os and the predicted common cis-regulatory elements in their promoter regions, we suggest that the expression patterns of OsDof12 and OsDof12os might be attributed to the basically common nature of the two promoters.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/80</link>
			
			 	<dc:creator>Dejun Li, Chunhua Yang, Xiaobing Li, Guobiao Ji and Lihuang Zhu</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:80</dc:source>
			<dc:date>2008-09-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-80</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>80</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/79">
            
            <title>Evaluation of suitable reference genes for gene expression studies in bovine muscular tissue</title>
			<description>Background:
Real-time reverse transcriptase quantitative polymerase chain reaction (real-time RTqPCR) is a technique used to measure mRNA species copy number as a way to determine key genes involved in different biological processes. However, the expression level of these key genes may vary among tissues or cells not only as a consequence of differential expression but also due to different factors, including choice of reference genes to normalize the expression levels of the target genes; thus the selection of reference genes is critical for expression studies. For this purpose, ten candidate reference genes were investigated in bovine muscular tissue.
Results:
The value of stability of ten candidate reference genes included in three groups was estimated: the so called 'classical housekeeping' genes (18S, GAPDH and ACTB), a second set of genes used in expression studies conducted on other tissues (B2M, RPII, UBC and HMBS) and a third set of novel genes (SF3A1, EEF1A2 and CASC3). Three different statistical algorithms were used to rank the genes by their stability measures as produced by geNorm, NormFinder and Bestkeeper. The three methods tend to agree on the most stably expressed genes and the least in muscular tissue. EEF1A2 and HMBS followed by SF3A1, ACTB, and CASC3 can be considered as stable reference genes, and B2M, RPII, UBC and GAPDH would not be appropriate. Although the rRNA-18S stability measure seems to be within the range of acceptance, its use is not recommended because its synthesis regulation is not representative of mRNA levels.
Conclusion:
Based on geNorm algorithm, we propose the use of three genes SF3A1, EEF1A2 and HMBS as references for normalization of real-time RTqPCR in muscle expression studies.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/79</link>
			
			 	<dc:creator>Raquel P&#233;rez, Isabel Tupac-Yupanqui and Susana Dunner</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:79</dc:source>
			<dc:date>2008-09-11</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-79</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>79</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-11</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/78">
            
            <title>Selection of internal reference genes for SYBR green qRT-PCR studies of rhesus monkey (Macaca mulatta) tissues</title>
			<description>Background:
The rhesus monkey (Macaca mulatta) is a valuable and widely used model animal for biomedical research. However, quantitative analyses of rhesus gene expression profiles under diverse experimental conditions are limited by a shortage of suitable internal controls for the normalization of mRNA levels. In this study, we used a systematic approach for the selection of potential reference genes in the rhesus monkey and compared their suitability to that of the corresponding genes in humans.
Results:
Eight housekeeping genes (HKGs) (GAPDH, SDHA, ACTB, RPL13A, RPL32, UBA52, PGK1Y, and YWHAZ) from rhesus monkeys and humans were selected to test for normalization of expression levels in six different tissue types (brain, colon, kidney, liver, lung, and stomach). Their stability and suitability as reference genes were validated by geNorm, NormFinder and BestKeeper programs. Intriguingly, RPL13A and RPL32 were selected as ideal reference genes only in rhesus monkeys.
Conclusion:
The results clearly indicated the necessity of using different reference genes for normalization of expression levels between rhesus monkeys and humans in various tissues.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/78</link>
			
			 	<dc:creator>Kung Ahn, Jae-Won Huh, Sang-Je Park, Dae-Soo Kim, Hong-Seok Ha, Yun-Ji Kim, Ja-Rang Lee, Kyu-Tae Chang and Heui-Soo Kim</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:78</dc:source>
			<dc:date>2008-09-10</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-78</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>78</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/77">
            
            <title>Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR</title>
			<description>Background:
Phi29 polymerase based amplification methods provides amplified DNA with minimal changes in sequence and relative abundance for many biomedical applications. RNA virus detection using microarrays, however, can present a challenge because phi29 DNA polymerase cannot amplify RNA nor small cDNA fragments (&lt;2000 bases) obtained by reverse transcription of certain viral RNA genomes. Therefore, ligation of cDNA fragments is necessary prior phi29 polymerase based amplification. We adapted the QuantiTect Whole Transcriptome Kit (Qiagen) to our purposes and designated the method as Whole Transcriptome Amplification (WTA).
Results:
WTA successfully amplified cDNA from a panel of RNA viruses representing the diversity of ribovirus genome sizes. We amplified a range of genome copy numbers from 15 to 4 &#215; 107 using WTA, which yielded quantities of amplified DNA as high as 1.2 &#956;g/&#956;l or 1010 target copies. The amplification factor varied between 109 and 106. We also demonstrated that co-amplification occurred when viral RNA was mixed with bacterial DNA.
Conclusion:
This is the first report in the scientific literature showing that a modified WGA (WTA) approach can be successfully applied to viral genomic RNA of all sizes. Amplifying viral RNA by WTA provides considerably better sensitivity and accuracy of detection compared to random RT-PCR.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/77</link>
			
			 	<dc:creator>Nicolas Berthet, Anita K Reinhardt, India Leclercq, Sven van Ooyen, Christophe Bat&#233;jat, Philip Dickinson, Rayna Stamboliyska, Iain G Old, Katherine A Kong, Laurent Dacheux, Herv&#233; Bourhy, Giulia C Kennedy, Christian Korfhage, Stewart T Cole and Jean-Claude Manuguerra</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:77</dc:source>
			<dc:date>2008-09-04</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-77</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>77</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-04</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/76">
            
            <title>Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer</title>
			<description>The discovery of microRNAs (miRNAs) added an extra level of intricacy to the already complex system regulating gene expression. These single-stranded RNA molecules, 18&#8211;25 nucleotides in length, negatively regulate gene expression through translational inhibition or mRNA cleavage. The discovery that aberrant expression of specific miRNAs contributes to human disease has fueled much interest in profiling the expression of these molecules. Real-time quantitative PCR (RQ-PCR) is a sensitive and reproducible gene expression quantitation technique which is now being used to profile miRNA expression in cells and tissues. To correct for systematic variables such as amount of starting template, RNA quality and enzymatic efficiencies, RQ-PCR data is commonly normalised to an endogenous control (EC) gene, which ideally, is stably-expressed across the test sample set. A universal endogenous control suitable for every tissue type, treatment and disease stage has not been identified and is unlikely to exist, so, to avoid introducing further error in the quantification of expression data it is necessary that candidate ECs be validated in the samples of interest. While ECs have been validated for quantification of mRNA expression in various experimental settings, to date there is no report of the validation of miRNA ECs for expression profiling in breast tissue. In this study, the expression of five miRNA genes (let-7a, miR-10b, miR-16, miR-21 and miR-26b) and three small nucleolar RNA genes (RNU19, RNU48 and Z30) was examined across malignant, benign and normal breast tissues to determine the most appropriate normalisation strategy. This is the first study to identify reliable ECs for analysis of miRNA by RQ-PCR in human breast tissue.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/76</link>
			
			 	<dc:creator>Pamela A Davoren, Roisin E McNeill, Aoife J Lowery, Michael J Kerin and Nicola Miller</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:76</dc:source>
			<dc:date>2008-08-21</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-76</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>76</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/75">
            
            <title>Normalisation genes for expression analyses in the brown alga model Ectocarpus siliculosus</title>
			<description>Background:
Brown algae are plant multi-cellular organisms occupying most of the world coasts and are essential actors in the constitution of ecological niches at the shoreline. Ectocarpus siliculosus is an emerging model for brown algal research. Its genome has been sequenced, and several tools are being developed to perform analyses at different levels of cell organization, including transcriptomic expression analyses. Several topics, including physiological responses to osmotic stress and to exposure to contaminants and solvents are being studied in order to better understand the adaptive capacity of brown algae to pollution and environmental changes. A series of genes that can be used to normalise expression analyses is required for these studies.
Results:
We monitored the expression of 13 genes under 21 different culture conditions. These included genes encoding proteins and factors involved in protein translation (ribosomal protein 26S, EF1alpha, IF2A, IF4E) and protein degradation (ubiquitin, ubiquitin conjugating enzyme) or folding (cyclophilin), and proteins involved in both the structure of the cytoskeleton (tubulin alpha, actin, actin-related proteins) and its trafficking function (dynein), as well as a protein implicated in carbon metabolism (glucose 6-phosphate dehydrogenase). The stability of their expression level was assessed using the Ct range, and by applying both the geNorm and the Normfinder principles of calculation.
Conclusion:
Comparisons of the data obtained with the three methods of calculation indicated that EF1alpha (EF1a) was the best reference gene for normalisation. The normalisation factor should be calculated with at least two genes, alpha tubulin, ubiquitin-conjugating enzyme or actin-related proteins being good partners of EF1a. Our results exclude actin as a good normalisation gene, and, in this, are in agreement with previous studies in other organisms.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/75</link>
			
			 	<dc:creator>Aude Le Bail, Simon M Dittami, Pierre-Olivier de Franco, Sylvie Rousvoal, Mark J Cock, Thierry Tonon and B&#233;n&#233;dicte Charrier</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:75</dc:source>
			<dc:date>2008-08-18</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-75</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>75</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2199/9/74">
            
            <title>Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells</title>
			<description>Background:
RNA polymerase (pol) III transcription is specifically elevated in a variety of cancers and is a target of regulation by a variety of tumor suppressors and oncogenes. Accurate initiation by RNA pol III is dependent on TFIIIB. In higher eukaryotes, two forms of TFIIIB have been characterized. TFIIIB required for proper initiation from gene internal RNA pol III promoters is comprised of TBP, Bdp1, and Brf1. Proper initiation from gene external RNA pol III promoters requires TBP, Bdp1, and Brf2. We hypothesized that deregulation of RNA polymerase III transcription in cancer may be a consequence of altered TFIIIB expression
Results:
Here, we report: (1) the TFIIIB subunits Brf1 and Brf2 are differentially expressed in a variety of cancer cell lines: (2) the Brf1 and Brf2 promoters differ in activity in cancer cell lines, and (3) VAI transcription is universally elevated, as compared to U6, in breast, prostate and cervical cancer cells.
Conclusion:
Deregulation of TFIIIB-mediated transcription may be an important step in tumor development. We demonstrate that Brf1 and Brf2 mRNA are differentially expressed in a variety of cancer cells and that the Brf2 promoter is more active than the Brf1 promoter in all cell lines tested. We also demonstrate, that Brf1-dependent VAI transcription was significantly higher than the Brf2-dependent U6 snRNA transcription in all cancer cell lines tested. The data presented suggest that Brf2 protein expression levels correlate with U6 promoter activity in the breast, cervical and prostate cell lines tested. Interestingly, the Brf1 protein levels did not vary considerably in HeLa, MCF-7 and DU-145 cells, yet Brf1 mRNA expression varied considerably in breast, prostate and cervical cancer cell lines tested. Thus, Brf1 promoter activity and Brf1 protein expression levels did not correlate well with Brf1-dependent transcription levels. Taken together, we reason that deregulation of Brf1 and Brf2 expression could be a key mechanism responsible for the observed deregulation of RNA pol III transcription in cancer cells.</description>
			<link>http://www.biomedcentral.com/1471-2199/9/74</link>
			
			 	<dc:creator>Stephanie Cabarcas, Joby Jacob, Ingrid Veras and Laura Schramm</dc:creator>
			
			<dc:source>BMC Molecular Biology 2008, 9:74</dc:source>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1471-2199-9-74</dc:identifier>
			
			
							
					<prism:publicationName>BMC Molecular Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2199</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>74</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
